Your session is about to expire
← Back to Search
Behavioral Intervention
Healthy Minds Online Group Intervention for Mood Disorders
N/A
Recruiting
Led By Marc Corbière, PhD
Research Sponsored by Université du Québec a Montréal
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up follow-ups at six months and 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial evaluates the impact of an online group intervention called Healthy Minds on helping people with mood disorders return to work and improve their health and work-related outcomes.
Who is the study for?
This trial is for individuals currently on sick leave or who have recently returned to work (less than a month) due to mood disorders such as depression or adjustment disorder. Participants must be in the process of returning to work and not have received CBT-type interventions before. They should also be able to communicate in French.
What is being tested?
The Healthy Minds online group intervention is being tested, which aims at helping people with mood disorders return to work sustainably. The study compares outcomes like mental health and job performance between those who receive this intervention and those who do not over one year.
What are the potential side effects?
Since Healthy Minds is a psychological online group intervention focusing on cognitive-behavioral techniques, it may cause emotional discomfort or stress initially but does not typically result in physical side effects.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ follow-ups at six months and 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~follow-ups at six months and 12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Anxiety symptoms
Cognitive biases
Cognitive difficulties
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Online group intervention "Healthy Minds"Experimental Treatment1 Intervention
Group II: Control groupActive Control1 Intervention
Like the intervention group, the control group will complete an online set of questionnaires at the following time points:
* Baseline
* First follow-up (2 months after baseline)
* Second follow-up (6 months after baseline)
* Third follow-up (12 months after baseline)
The questionnaires will cover the following domains:
* Sociodemographic and biopsychosocial factors
* Symptoms associated with the primary mood disorder
* Cognitive difficulties and distortions
* Self-efficacy in relation to returning to work
* Work accommodations and natural supports
* Relationship with immediate supervisor
* Work functioning
* Return-to-work time (number of days away from work)
Find a Location
Who is running the clinical trial?
Université du Québec a MontréalLead Sponsor
24 Previous Clinical Trials
5,313 Total Patients Enrolled
Ciusss de L'Est de l'Île de MontréalOTHER
78 Previous Clinical Trials
6,335 Total Patients Enrolled
PhysioExtraUNKNOWN
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a diagnosed organic disorder.I have undergone cognitive behavioral therapy.I am returning to work after treatment for depression or anxiety.I cannot communicate in French.I returned less than a month ago.
Research Study Groups:
This trial has the following groups:- Group 1: Online group intervention "Healthy Minds"
- Group 2: Control group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger